Category Archives: Ethics, Research & Health


Scientific research and technological development make a major contribution to the integral development and the quality of life of human beings, especially, but not only, in the area of health where new therapeutic options become increasingly available. They are also an important motor of economic growth. COMECE chiefly covers the bioethical issues that arise at the EU level in the ambits of health and of research, although the main competences with regard to these matters remain largely at the Member States’ level. COMECE is assisted in this mission by a Working Group on Ethics.

News

Do not be misled: abortion is not a EU competence

In the context of the Vote today at the European Parliament of an own initiative Report on “Sexual and Reproductive Health and Rights” which includes abortion, COMECE recalls that the EU has no competence in regard to this matter. EU citizens should not be misled. Article 168 § 7of the Treaty on the Functioning of the EU states that the ‘‘Union action shall respect the … Continue reading »

News

COMECE’s Opinion on Medical Devices: Not safe enough

In an Opinion published today, the COMECE Reflection Group on Bioethics, while welcoming the ongoing revision of European legislation on Medical Devices, warns against some ethical shortcomings and proposes improvements to Proposals which will be voted in the Environment, Public Health and Food Safety Committee of the European Parliament on 18 September. There are currently around half a million medical devices (MDs) on the market … Continue reading »

News

Clinical trials on medicinal products for human use in the EU: A sound ethical framework is essential

Clinical trials are necessary before any new medicine is put on the market. However, many people who are unable to give consent as well as people from less-developed countries often participate in such trials. So how can we better protect these people and vulnerable populations against abuse? The European Commission has proposed a regulation which will be submitted to a vote of the European Parliament … Continue reading »

News

COMECE welcomes today’s announcement of the Nobel Prize for Medicine for research on alternatives to embryonic stem cells research

In contrast, there have been continuing scientific advances in fields of research involving alternative stem cells (adult, derived from umbilical cord or induced pluripotent) which present better prospects for clinical applications; or have indeed already demonstrated widespread clinical results (and do not raise any special ethical problems). Today’s Nobel Prize rewards such efforts to discover alternatives to hESC in mature, specialised cells that once reprogrammed … Continue reading »

News

Horizon 2020: The new ethical framework proposed is weaker than the current one

In Autumn this year the ITRE Committee (Industry, Research and Energy) of the European Parliament will vote the package of proposals for Horizon 2020, the EU’s new programme for research and innovation running from 2014 to 2020 with an €87 billion budget. Some major ethical problems remain and it appears that on many aspects the new framework is even weaker than the current one. In … Continue reading »

Press Release

Latest COMECE Reflections on Science and Bioethics

How can we deal with patients in state of post-coma unresponsiveness? What are the prospects for human enhancement by technological means? How can we fight organ trafficking and transplant tourism? What exactly are sexual and reproductive health rights? These are very technical yet nevertheless crucial topics with which EU lawmakers are more and more confronted. In order to offer an insight into the ethical implications … Continue reading »

News

EU should update its research policy on stem cells

Human embryonic stem cell research is no longer patentable in the EU, it is ethically problematic and therefore is not a consensual research field among Member States and EU citizens. Moreover, it offers less and less clinical promise. COMECE therefore calls on the EU to exclude human embryonic stem cell research from its upcoming research funding programme Horizon 2020 and to focus instead on the … Continue reading »